4.6 Article

GABAergic inhibition in visual cortical plasticity

Journal

FRONTIERS IN CELLULAR NEUROSCIENCE
Volume 4, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2010.00010

Keywords

GABA; critical period; ocular dominance plasticity; amblyopia; environmental enrichment

Categories

Funding

  1. Italian Ministry of the University
  2. Scientific and Technological Research COFIN

Ask authors/readers for more resources

Experience is required for the shaping and refinement of developing neural circuits during well defined periods of early postnatal development called critical periods. Many studies in the visual cortex have shown that intracortical GABAergic circuitry plays a crucial role in defining the time course of the critical period for ocular dominance plasticity. With the end of the critical period, neural plasticity wanes and recovery from the effects of visual defects on visual acuity (amblyopia) or binocularity is much reduced or absent. Recent results pointed out that intracortical inhibition is a fundamental limiting factor for adult cortical plasticity and that its reduction by means of different pharmacological and environmental strategies makes it possible to greatly enhance plasticity in the adult visual cortex, promoting ocular dominance plasticity and recovery from amblyopia. Here we focus on the role of intracortical GABAergic circuitry in controlling both developmental and adult cortical plasticity. We shall also discuss the potential clinical application of these findings to neurological disorders in which synaptic plasticity is compromised because of excessive intracortical inhibition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Neurosciences

Neuroplasticity of the visual cortex: in sickness and in health

Laura Baroncelli, Claudia Lunghi

Summary: Brain plasticity refers to the ability of synaptic connections in the brain to adapt their function and structure based on experience such as environmental changes, sensory deprivation, and injuries. Despite being more prominent in the developing nervous system, studies have shown that the adult cerebral cortex also retains a significant degree of plasticity. Strategies to enhance this plastic potential could lead to novel therapeutic approaches for treating amblyopia and other neurodevelopmental disorders. Additionally, understanding how the visual system adjusts to neurodegenerative conditions and the crucial role of spared plasticity in visual system for sight recovery is important for treating blindness.

EXPERIMENTAL NEUROLOGY (2021)

Article Biophysics

Glial-fibrillary-acidic-protein (GFAP) biomarker detection in serum-matrix: Functionalization strategies and detection by an ultra-high-frequency surface-acoustic-wave (UHF-SAW) lab-on-chip

M. Agostini, F. Amato, M. L. Vieri, G. Greco, I. Tonazzini, L. Baroncelli, M. Caleo, E. Vannini, M. Santi, G. Signore, M. Cecchini

Summary: GFAP has attracted attention as a promising biomarker for pathologies affecting the human central nervous system, with potential applications in clinical diagnostics for multiple brain-pathology biomarkers.

BIOSENSORS & BIOELECTRONICS (2021)

Article Biochemistry & Molecular Biology

Visual Cortex Engagement in Retinitis Pigmentosa

Gianluca Pietra, Tiziana Bonifacino, Davide Talamonti, Giambattista Bonanno, Alessandro Sale, Lucia Galli, Laura Baroncelli

Summary: RP is a genetic disorder that causes progressive degeneration of retinal photoreceptors. While there is currently no cure, recent research focuses on preserving existing photoreceptors or substituting light-responsive elements to improve residual visual sensitivity in RP. Visual recovery also depends on the integrity of the visual system beyond photoreceptors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Genetics & Heredity

The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development

Elsa Ghirardini, Francesco Calugi, Giulia Sagona, Federica Di Vetta, Martina Palma, Roberta Battini, Giovanni Cioni, Tommaso Pizzorusso, Laura Baroncelli

Summary: CTD is an X-linked metabolic disorder caused by mutations in the SLC6A8 gene, leading to intellectual disability, autistic behavior, and epilepsy. There is no effective treatment for CTD, making research on novel intervention strategies a major scientific challenge. Animal models are crucial for studying the disease mechanisms and developing therapeutics, with rodent models showing promise in recapitulating human CTD phenotypes.

GENES (2021)

Article Cardiac & Cardiovascular Systems

Creatine deficiency and heart failure

Annamaria Del Franco, Giuseppe Ambrosio, Laura Baroncelli, Tommaso Pizzorusso, Andrea Barison, Iacopo Olivotto, Fabio A. Recchia, Carlo M. Lombardi, Marco Metra, Yu F. Ferrari Chen, Claudio Passino, Michele Emdin, Giuseppe Vergaro

Summary: Impaired cardiac energy metabolism is proposed as a common mechanism in various heart failure causes, with researchers focusing on the energy-depletion hypothesis. The creatine kinase system plays a vital role in the heart, with creatine levels reflecting disease severity, contractile dysfunction, and myocardial remodelling in heart failure.

HEART FAILURE REVIEWS (2022)

Article Psychiatry

The amplitude of fNIRS hemodynamic response in the visual cortex unmasks autistic traits in typically developing children

Raffaele Mazziotti, Elena Scaffei, Eugenia Conti, Viviana Marchi, Riccardo Rizzi, Giovanni Cioni, Roberta Battini, Laura Baroncelli

Summary: Autistic traits exist as a continuum dimension in the population, with ASD as the extreme end of the spectrum. Evidence suggests that neuroanatomical and neurofunctional characteristics in relatives of individuals with ASD represent an intermediate neurobiological pattern. This highlights the potential of utilizing quantitative measures of autistic traits in the general population as biomarkers for early identification of ASD-related pathophysiological processes. Additionally, fNIRS shows promise as a tool for assessing brain function, with potential applications in differential diagnosis, treatment analysis, and personalized medicine for various neurological conditions.

TRANSLATIONAL PSYCHIATRY (2022)

Review Neurosciences

Looking for fNIRS Signature in Autism Spectrum: A Systematic Review Starting From Preschoolers

Eugenia Conti, Elena Scaffei, Chiara Bosetti, Viviana Marchi, Valeria Costanzo, Valerio Dell'Oste, Raffaele Mazziotti, Liliana Dell'Osso, Claudia Carmassi, Filippo Muratori, Laura Baroncelli, Sara Calderoni, Roberta Battini

Summary: Accumulating evidence suggests that functional Near-Infrared Spectroscopy (fNIRS) can provide insights into neural circuit organization and cortical activity in the developing brain. fNIRS measures neurovascular coupling to study brain functions through changes in cerebral blood flow and oxygenation levels. The interest in identifying fNIRS as a potential biomarker for early diagnosis and treatment outcome in neurodevelopmental disorders (NDDs) is reflected in the increasing number of scientific publications on this topic. This systematic review focuses on the clinical applications of fNIRS in NDDs, particularly in preschool children. The selected studies indicate that fNIRS shows promise in identifying early quantitative biomarkers for Autism Spectrum Disorder (ASD) through resting-state functional connectivity and task-evoked brain activation.

FRONTIERS IN NEUROSCIENCE (2022)

Article Cell Biology

Perturbation of Cortical Excitability in a Conditional Model of PCDH19 Disorder

Didi Lamers, Silvia Landi, Roberta Mezzena, Laura Baroncelli, Vinoshene Pillai, Federica Cruciani, Sara Migliarini, Sara Mazzoleni, Massimo Pasqualetti, Maria Passafaro, Silvia Bassani, Gian Michele Ratto

Summary: This study investigates the effects of mosaic PCDH19 expression on cortical networks in relation to PCDH19 epilepsy. The results show that a focal mosaic mutation of PCDH19 disrupts cortical networks and leads to disruptions in sleep patterns.

CELLS (2022)

Article Biochemistry & Molecular Biology

Oral Feeding of an Antioxidant Cocktail as a Therapeutic Strategy in a Mouse Model of Rett Syndrome: Merits and Limitations of Long-Term Treatment

Laura Baroncelli, Stefanie Auel, Lena Rinne, Ann-Kathrin Schuster, Victoria Brand, Belinda Kempkes, Katharina Dietrich, Michael Mueller

Summary: Rett syndrome is a severe neurodevelopmental disorder caused by mutations in the MECP2 gene. Antioxidant treatment has shown some therapeutic benefits, but long-term treatment may lose efficacy and worsen metabolic disturbances.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications

Mariacristina Gagliardi, Sara Chiarugi, Chiara De Cesari, Giulia Di Gregorio, Alessandra Diodati, Laura Baroncelli, Marco Cecchini, Ilaria Tonazzini

Summary: The study presents a method to obtain stable and cytocompatible crosslinked chitosan nanoparticles for intranasal drug delivery. The nanoparticles showed a stable size and surface charge, and exhibited good cytocompatibility in vitro. This synthetic system has potential as a drug carrier for intranasal delivery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Polymer Science

Stabilized Reversed Polymeric Micelles as Nanovector for Hydrophilic Compounds

Mariacristina Gagliardi, Agnese Vincenzi, Laura Baroncelli, Marco Cecchini

Summary: Small hydrophilic drugs are commonly used in systemic administration but have limitations due to poor absorption and fast clearance. Nanoencapsulation of these drugs in compartmented particles, such as liposomes or extracellular vesicles, can enhance their biodistribution, targeted delivery, and pharmaceutical efficacy. In this study, we developed polymeric stabilized reversed micelles as a system for encapsulating hydrophilic drugs. The optimized preparation procedure and stabilization strategy improved the stability of the micelles. These micelles showed potential as drug carriers, with the ability to load and deliver creatine. The results suggest that this system can be further explored for different drug cargoes.

POLYMERS (2023)

Article Neurosciences

Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency

Aloise Mabondzo, Rania Harati, Lea Broca-Brisson, Anne-Cecile Guyot, Narciso Costa, Francesco Cacciante, Elena Putignano, Laura Baroncelli, Matthew R. Skelton, Cathy Saab, Emmanuelle Martini, Henri Benech, Thomas Joudinaud, Jean-Charles Gaillard, Jean Armengaud, Rifat Hamoudi

Summary: Creatine transporter deficiency (CTD) is a genetic disorder that impairs the uptake of creatine into the brain, leading to intellectual disability. This study investigated the therapeutic potential of dodecyl creatine ester (DCE) in a mouse model of CTD and identified biomarkers associated with cognitive improvement. The findings shed light on the pathogenesis of CTD and provide insights for potential treatments.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2023)

Article Neurosciences

Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency

Elsa Ghirardini, Giulia Sagona, Angel Marquez-Galera, Francesco Calugi, Carmen M. Navarron, Francesco Cacciante, Siwei Chen, Federica Di Vetta, Lorenzo Dada, Raffaele Mazziotti, Leonardo Lupori, Elena Putignano, Pierre Baldi, Jose P. Lopez-Atalaya, Tommaso Pizzorusso, Laura Baroncelli

Summary: This study found that the absence of cellular creatine affects the function of specific neurons, which may be one of the causes of Creatine Transporter Deficiency (CTD). Additionally, the study identified a potential therapeutic approach targeting these neurons to improve CTD symptoms.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Neurosciences

A Potential Biomarker of Brain Activity in Autism Spectrum Disorders: A Pilot fNIRS Study in Female Preschoolers

Elena Scaffei, Raffaele Mazziotti, Eugenia Conti, Valeria Costanzo, Sara Calderoni, Andrea Stoccoro, Claudia Carmassi, Raffaella Tancredi, Laura Baroncelli, Roberta Battini

Summary: Autism spectrum disorder (ASD) is a challenging neurodevelopmental condition to detect in young females due to the heterogeneity of the behavioral phenotype and the capacity of camouflage. Functional Near-infrared Spectroscopy (fNIRS) is a non-invasive tool that can quantify cortical hemodynamic responses (HDR) and potentially serve as a biomarker for ASD in females. A case-control study on high-functioning preschooler females with ASD demonstrated the feasibility of using visual fNIRS measurements to discriminate between ASD and typical subjects based on signal features such as vHDR amplitude and lateralization. The level of response lateralization was also found to be correlated with the severity of autistic traits, highlighting the importance of sensory symptoms in ASD.

BRAIN SCIENCES (2023)

Article Geriatrics & Gerontology

Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline

Simona Cintoli, Claudia Radicchi, Marianna Noale, Stefania Maggi, Giuseppe Meucci, Gloria Tognoni, Ubaldo Bonuccelli, Alessandro Sale, Nicoletta Berardi, Lamberto Maffei

Summary: The study aimed to test the effects of physical and cognitive training on neuropsychiatric symptoms and quality of life in patients with mild cognitive impairment. Results showed that after 7 months of training, participants in the training group exhibited a significant reduction in neuropsychiatric symptoms and a significant increase in quality of life compared to the control group.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

No Data Available